Conference Coverage
Conference Coverage
08/23/2024
Researchers set out to determine whether attention-deficit/hyperactivity disorder predisposes individuals to the development of neuropsychiatric symptoms. The researchers presented their findings at the...
08/23/2024
Research summary
Research summary
07/23/2024
A team of researchers sought to determine the prevalence of depression and anxiety in patients with NMOSD before their diagnosis of the disease.
07/23/2024
Research Summary
Research Summary
06/05/2024

Jessica Ganga

Jessica Ganga
A team of researchers sought to establish the risk of a patient developing dementia after experiencing a stroke.
06/05/2024
Conference Coverage
Conference Coverage
05/31/2024

Jessica Ganga

Jessica Ganga
Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
05/31/2024
research summary
research summary
04/19/2024
Individuals with acute hepatic porphyria often experience acute attacks and chronic symptoms which greatly diminish their quality of life. Researchers examined the efficacy of givosiran in reducing these...
04/19/2024
Research Summary
Research Summary
03/28/2024

Jessica Ganga

Jessica Ganga
Researchers investigated whether survivors of stroke could take two common types of antidepressant medications—SSRIs and SNRIs—and evaluated if serious bleeding occurred among patients. Their findings were...
03/28/2024
Research Summary
Research Summary
03/14/2024

Jessica Ganga

Jessica Ganga
A diverse team of experts representing the National Association of Epilepsy Centers updated a set of guidelines and recommendations for the care of patients with epilepsy.
03/14/2024
FDA alert
FDA alert
11/14/2023

Jessica Ganga

Jessica Ganga
The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.
11/14/2023
Treatment
Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
treatment
treatment
05/19/2022
The FDA has approved a new form of treatment for adults with amyotrophic lateral sclerosis, commonly known as Lou Gehrig disease.
05/19/2022